Single-crystal metal nanocrystals
    3.
    发明申请
    Single-crystal metal nanocrystals 审中-公开
    单晶金属纳米晶体

    公开(公告)号:US20070298536A1

    公开(公告)日:2007-12-27

    申请号:US11731384

    申请日:2007-03-30

    IPC分类号: H01L21/06

    CPC分类号: C30B7/14 B82Y30/00 C30B29/60

    摘要: Methods for producing nanocrystals comprising metallic materials utilizing an inverse micelle solvothermal process are disclosed. Nanocrystals comprising well-ordered, single-crystalline germanium (Ge) materials with predeterminable morphologies in relatively high purity are produced by suspending a Ge salt material comprising a metal ion in a non-aqueous inverse micelle solvent comprising at least one surfactant, and introducing a reducing agent to the non-aqueous inverse micelle solvent to reduce a plurality of metal ions to form a ordered single-crystalline Ge nanocrystal.

    摘要翻译: 公开了使用反胶束溶剂热法制备包含金属材料的纳米晶体的方法。 通过将包含金属离子的Ge盐材料悬浮在包含至少一种表面活性剂的非水性反胶束溶剂中来制备包含具有相对高纯度的可预测形态的有序的单晶锗(Ge)材料的纳米晶体,并引入 还原剂到非水反相胶束溶剂中以还原多个金属离子以形成有序的单晶Ge纳米晶体。

    Acyl-CoA dehydrogenase allenic inhibitors
    5.
    发明授权
    Acyl-CoA dehydrogenase allenic inhibitors 失效
    酰基辅酶A脱氢酶allenic抑制剂

    公开(公告)号:US07045547B2

    公开(公告)日:2006-05-16

    申请号:US10223385

    申请日:2002-08-20

    CPC分类号: C07C327/30 C07H19/20

    摘要: Compounds of formula I wherein A is R3, OR3, SR3, and NR3R4; and R1, R2, R3 and R4 are as defined. The compounds of the invention are reversible inhibitors of acyl-CoA dehydrogenase, and are useful in treating disorders such as diabetes, heart diseases (including angina and congestive heart failure), and peripheral vascular disease in patients suffering from these diseases or conditions resulting thereof.

    摘要翻译: 其中A为R 3,OR 3,SR 3和NR 3的式I化合物 > 4 ; 且R 1,R 2,R 3和R 4如上所定义。 本发明的化合物是酰基辅酶A脱氢酶的可逆抑制剂,并且可用于治疗患有这些疾病或病症的患者中的疾病如糖尿病,心脏病(包括心绞痛和充血性心力衰竭)和外周血管疾病。

    Process for preparing 4-acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the intermediates thereof
    6.
    发明授权
    Process for preparing 4-acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the intermediates thereof 失效
    制备4-乙酰基-2,3,4,5-四氢 - 苯并[1,4]二氮杂的方法及其中间体

    公开(公告)号:US08242264B2

    公开(公告)日:2012-08-14

    申请号:US12601962

    申请日:2008-05-22

    IPC分类号: C07D243/14 C07C205/06

    摘要: The present invention relates to a process for preparing 4-acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the intermediates thereof. The present invention provides a compound represented by formula I and a compound represented by formula II, and processes for preparing 4-acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine by using the compound represented by formula I, the compound represented by formula II and o-nitrobenzaldehyde. The invention has the advantages of the shorter synthesis steps, easily available raw materials and simple operation. Moreover, the process is economic and safe by avoiding the use of expensive and dangerous lithium aluminum hydride.

    摘要翻译: 本发明涉及一种制备4-乙酰基-2,3,4,5-四氢 - 苯并[1,4]二氮杂的方法及其中间体。 本发明提供由式I表示的化合物和由式II表示的化合物,以及通过使用式(I)表示的化合物制备4-乙酰基-2,3,4,5-四氢 - 苯并[1,4]二氮杂 I,式II表示的化合物和邻硝基苯甲醛。 本发明具有合成步骤较短,原料易得,操作简单等优点。 此外,通过避免使用昂贵且危险的氢化铝锂,该方法是经济和安全的。